This content is from the Advance Chapters of the NEW Where There Is No Doctor. You can download this chapter in Bangla, English, Haitian Kreyol, Lao, Nepali, Spanish, and Swahili
WHO Package of Essential NCD Interventions (PEN)
Accessed March 18,2019
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing hyperglycaemia in the WHO Package of Essential NCD Interventions (WHO PEN) for primary care in low-resources settings, reviewing several newer oral agents as second- and third-line treatment: dipeptidyl peptidase-4 inhibitors, sodium-glucose co-transporter 2 inhibitors and thiazolidinediones. The guidelines also present recommendations on the selection of type of insulin (analogue versus human insulin) for adults with type 1 and type 2 diabetes.
Available in English, Spanish, French, Arabic , Chinese and Russian
Large File. Please download directly from the website
An Interactive Version of the English, French and Spanish Version is available, too.
Disponible en anglais, espagnol, français, arabe, chinois et russe
Disponible en inglés, español, francés, árabe, chino y ruso
Доступно на английском, испанском, французском, арабском, китайском и русском
Diabetes Care2018;42(Suppl. 1):S1–S194.
New criteria for classifying and diagnosing hyperglycaemia first detected during pregnancy have been accepted by a group of experts convened by WHO. These new criteria are an update of recommendations published by WHO in 1999
A Manual for Medical Officer
Developed under the Government of India – WHO Collaborative Programme 2008-2009
JIMSA Jan.-March 2015 Vol. 28 no.1 p.47-50e